Acro Biomedical ACBM
OTC ACBM
$0.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Acro Biomedical (ACBM) Receivables - Net (2021 - 2023)

Updated

Acro Biomedical's Receivables - Net came in at $498,500 for Q2 2023, up 67.0% from $298,500 a year earlier but down 18.1% from the prior quarter.

Analysis

Acro Biomedical (ACBM) Receivables - Net (2021 - 2023) Analysis & Trends

At the end of FY2022, Acro Biomedical's Receivables - Net was $638,500, up 6.8% from FY2021.

  • Going back by year, Receivables - Net was $598,000 in FY2021.
  • The five-year range for quarterly Receivables - Net is $278,500 (Q3 2022) to $638,500 (Q4 2022).
  • Year-over-year, Receivables - Net has increased for three consecutive quarters.
  • Business Quant data shows ACBM's Receivables - Net at $608,500 (Q1 2023), $638,500 (Q4 2022) and $278,500 (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 346.43 Bn 302.42 Bn 10.28 Bn
2 Colgate Palmolive 69.04 Bn 64.10 Bn 3.30 Bn
3 Estee Lauder Companies 34.63 Bn 22.70 Bn 2.74 Bn
4 Kenvue 34.35 Bn 29.97 Bn 2.30 Bn
5 Kimberly Clark 32.85 Bn 30.17 Bn 1.60 Bn
6 Church & Dwight 22.69 Bn 21.21 Bn 693.90 Mn
7 Clorox 9.84 Bn 8.28 Bn 804.00 Mn
8 e.l.f. Beauty 6.00 Bn 4.97 Bn 398.84 Mn
9 Reynolds Consumer Products 4.65 Bn 4.32 Bn 245.00 Mn
10 Acro Biomedical 1.80 Mn 1.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 498,500.00
Mar 31, 2023 608,500.00
Dec 31, 2022 638,500.00
Sep 30, 2022 278,500.00
Jun 30, 2022 298,500.00
Mar 31, 2022 298,500.00
Dec 31, 2021 598,000.00
API Access

Acro Biomedical Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=ACBM&period=max&api_key=YOUR_API_KEY